The goal of the European and Developing Countries Clinical Trials Partnership (EDCTP) is to reduce the social and economic burden of poverty-related diseases in developing countries, in particular sub-Saharan Africa, by accelerating the clinical development of effective, safe, accessible, suitable and affordable medical interventions for HIV/AIDS, tuberculosis, malaria and neglected infectious diseases.

The grant is a two-stage application procedure. For the first stage, a letter of intent must be submitted by the first deadline. Successful applicants will then be invited to submit a full proposal for the second stage.

Projects should focus on validation of the clinical performance and/or implementation of new or improved diagnostic tools and technologies for poverty-related diseases. The proposed tools and technologies should improve the performance of diagnosis, prediction, monitoring, intervention or assessment of therapeutic response, with a significant impact on clinical decision and health outcomes. Proposals should focus on late stage development (e.g. evaluation and/or demonstration phase trials) or implementation studies in sub-Saharan Africa.

Eligibility: A proposal/application will only be considered eligible if Its content corresponds to the topic/contest description and it complies with the eligibility conditions set out below:

  • Consortia comprising a minimum of three independent legal entities are eligible to apply. Two of the legal entities shall be established in two different Participating States (European Partner States) and one of the legal entities must be established in a sub-Saharan African country. All three legal entities shall be independent of each other.
  • ‘Sole participants’ formed by several legal entities (e.g. European Research Infrastructure Consortia, European Groupings of Territorial Cooperation, central purchasing bodies) are eligible if the above-mentioned minimum conditions are satisfied by the legal entities forming together the sole participant.

Agencies Involved: European Union

Key Dates: Stage 1 typically closes in October; Stage 2 typically closes in March

Visit the website for more detailed information.